video
CBR: Umbilical Stem Cell Overview
Cord Blood Registry Launches Industry-Leading Innovations for Newborn Stem Cell Collection
New Collection System Offers Parents Opportunity to Preserve a Greater Number and Diversity of Their Newborn’s Umbilical Cord Stem Cells for More Potential Therapeutic Uses
Cord Blood Registry (CBR), the global leader in the collection and preservation of newborn stem cells from the umbilical cord, announced today the launch of its new stem cell collection system that saves a greater number and diversity of a newborn’s stem cells – from both the blood in the umbilical cord and the cord tissue itself – for a wider range of potential therapeutic uses.
Click link above for complete article.
Treatments Autologous Stem Cell Transplants
This video details autologous stem cell transplants and offers insightful animations of the procedure.
In an autologous stem cell transplant, you are your own donor. Your peripheral blood stem cells are taken from you, frozen until needed, then given back to you after you have received high doses of radiation therapy, chemotherapy, or both, to destroy cancer cells.
“An autologous stem cell transplant removes your bone marrow stem cells so that you can be given larger doses of chemotherapy and radiation. Following therapy, your unharmed stem cells are returned”
Cancer Treatment Centers of America
Primetime Special on Cord Blood Stem Cell Therapy
Two cerebral palsy patients and CBR clients who are experiencing positive results after undergoing reinfusion of their own cord blood stem cells were featured on the NBC San Francisco Bay Area show Health Matters: Stem Cell Therapy Today & Tomorrow.
Stem Cells: Developing New Cures
New York Stem Cell Foundation (NYSCF) has helped create a video on stem cell research currently playing in the Hall of Human Origins at the American Museum of Natural History in New York. It portrays the promise of stem cell therapies for human disease and demonstrates the potential of the research to create opportunities for studying disease fundamentals.
Stem Cells: Developing New Cures from NYSCF on Vimeo.
Adult Stem Cells Success Stories – Amy Daniels
StemCellResearchFacts.com – Amy Daniels was terrified when she learned that she had Scleroderma- a disease that causes the tissue in the skin, blood vessels, and muscles to harden. It’s known as the disease that turns people into stone. Amy was fortunate to get into a medical study that used Adult Stem Cells from her own body to save her life. She is now completely cured from the disease.
Stem Cells Primer – Video
From Sciencestage.com
Heart Stem Cells Show Promise
Play CBS Video
From CBSnews.com
Can a human heart repair itself? One heart is trying.
Heart attack patient Ken Milles is the first person ever to get an infusion of his own, laboratory-grown cardiac stem cells. Doctors at the Cedars-Sinai Heart Institute are trying to see if his own heart cells will fix the damaged area of his heart.
Milles is part of a 24-patient clinical trial, designed by Dr. Eduardo Marbán of Cedars-Sinai Heart Institute.
The trial procedure begins when healthy heart cells are collected from the patient’s heart. Next, the cells are off to the lab, where more stem cells are grown, along with complimentary heart cells. These cells then create complex cardiospheres which, Whitaker reported, can actually start beating in the petri dish. Then, doctors insert the lab-grown stem and support cells into the damaged area of the heart, with hopes that patients like Milles will benefit.
In Milles case, doctors hope to repair an area scarred by a heart attack.
If it works in humans as it has in animals, CBS News correspondent Bill Whitaker reports, the scarring caused by the heart attack, will begin to heal, the heart will grow new muscle, pump more blood — and perhaps give the patient a new lease on life.
Click link above for complete article.
Einstein On Stem Cell Research – video
PANEL DISCUSSION: Stem Cell Research & Diabetes: Realizing a Promise
At least 24 million American adults and children have diabetes and struggle with its many complications, including heart disease, amputation, and blindness. Scientists believe that stem cell research holds great promise in the quest for a cure for type 1 diabetes and provides a powerful tool for controlling type 2 diabetes.
In a panel discussion, leading stem cell scientists and patient advocates came together on April 29, 2009 to discuss the latest developments in stem cell research and diabetes. The discussion, organized by the New York Stem Cell Foundation (NYSCF), was open to the public and drew several hundred people to The Times Center in Manhattan.
Panelists:
Allen M. Spiegel, M.D., The Marilyn and Stanley M. Katz Dean of Albert Einstein College of Medicine
Dean Spiegel is the former director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes for Health (from 1996-2006). He is also a former vice chair (2005-2006) and member of the NIH Stem Cell Task Force (2002-2005) and has testified before the House and Senate on stem cell research. Dr. Spiegel provides an overview of the state of type 1 diabetes research from the perspective of a former NIDDK Director who helped shape the NIH research agenda.
